These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 3369092)
41. A new anti-human immunodeficiency virus substance, glycyrrhizin sulfate; endowment of glycyrrhizin with reverse transcriptase-inhibitory activity by chemical modification. Nakashima H; Matsui T; Yoshida O; Isowa Y; Kido Y; Motoki Y; Ito M; Shigeta S; Mori T; Yamamoto N Jpn J Cancer Res; 1987 Aug; 78(8):767-71. PubMed ID: 2443473 [TBL] [Abstract][Full Text] [Related]
42. Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Kobayashi N; Hamamoto Y; Yamamoto N; Ishii A; Yonehara M; Yonehara S Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9620-4. PubMed ID: 1702216 [TBL] [Abstract][Full Text] [Related]
43. Effect of pH on giant cell formation induced by human immunodeficiency virus ( HIV ). Yoshiyama H; Kajii T; Yamamoto N; Kobayashi N Biochem Biophys Res Commun; 1989 Feb; 158(3):973-9. PubMed ID: 2537642 [TBL] [Abstract][Full Text] [Related]
45. Neutralization of HIV-1 and inhibition of HIV-1-induced syncytia by 1,8-naphthalimide photoactive compound. Chanh TC; Lewis DE; Allan JS; Sogandares-Bernal F; Judy MM; Utecht RE; Matthews JL AIDS Res Hum Retroviruses; 1993 Sep; 9(9):891-6. PubMed ID: 8257636 [TBL] [Abstract][Full Text] [Related]
46. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Baba M; Pauwels R; Balzarini J; Arnout J; Desmyter J; De Clercq E Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6132-6. PubMed ID: 2457906 [TBL] [Abstract][Full Text] [Related]
47. Expression of HIV env gene in a human T cell line for a rapid and quantifiable cell fusion assay. Moir S; Poulin L AIDS Res Hum Retroviruses; 1996 Jun; 12(9):811-20. PubMed ID: 8738433 [TBL] [Abstract][Full Text] [Related]
48. The phorbol ester TPA strongly inhibits HIV-1-induced syncytia formation but enhances virus production: possible involvement of protein kinase C pathway. Chowdhury IH; Koyanagi Y; Kobayashi S; Hamamoto Y; Yoshiyama H; Yoshida T; Yamamoto N Virology; 1990 May; 176(1):126-32. PubMed ID: 1970444 [TBL] [Abstract][Full Text] [Related]
49. Determinants of syncytium formation in microglia by human immunodeficiency virus type 1: role of the V1/V2 domains. Shieh JT; Martín J; Baltuch G; Malim MH; González-Scarano F J Virol; 2000 Jan; 74(2):693-701. PubMed ID: 10623731 [TBL] [Abstract][Full Text] [Related]
50. Effect of Evans blue and trypan blue on syncytia formation and infectivity of human immunodeficiency virus type I and type II in vitro. Pal R; Mumbauer S; Hoke G; Larocca R; Myers C; Sarngadharan MG; Stein CA AIDS Res Hum Retroviruses; 1991 Jun; 7(6):537-43. PubMed ID: 1718343 [TBL] [Abstract][Full Text] [Related]
51. A natural sulfated polysaccharide, calcium spirulan, isolated from Spirulina platensis: in vitro and ex vivo evaluation of anti-herpes simplex virus and anti-human immunodeficiency virus activities. Hayashi K; Hayashi T; Kojima I AIDS Res Hum Retroviruses; 1996 Oct; 12(15):1463-71. PubMed ID: 8893054 [TBL] [Abstract][Full Text] [Related]
52. Assessment of the effect of phosphorylated metabolites of anti-human immunodeficiency virus and anti-hepatitis B virus pyrimidine analogs on the behavior of human deoxycytidylate deaminase. Liou JY; Krishnan P; Hsieh CC; Dutschman GE; Cheng YC Mol Pharmacol; 2003 Jan; 63(1):105-10. PubMed ID: 12488542 [TBL] [Abstract][Full Text] [Related]
53. Antiviral activities of glycyrrhizin and its modified compounds against human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 1 (HSV-1) in vitro. Hirabayashi K; Iwata S; Matsumoto H; Mori T; Shibata S; Baba M; Ito M; Shigeta S; Nakashima H; Yamamoto N Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):112-5. PubMed ID: 1646687 [TBL] [Abstract][Full Text] [Related]
54. Pradimicin A inhibition of human immunodeficiency virus: attenuation by mannan. Tanabe-Tochikura A; Tochikura TS; Yoshida O; Oki T; Yamamoto N Virology; 1990 Jun; 176(2):467-73. PubMed ID: 2345961 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of human immunodeficiency virus type-1 (HIV-1) glycoprotein-mediated cell-cell fusion by immunor (IM28). Mavoungou D; Poaty-Mavoungou V; Akoume MY; Ongali B; Mavoungou E Virol J; 2005 Feb; 2():9. PubMed ID: 15707492 [TBL] [Abstract][Full Text] [Related]
56. Linker-extended native cyanovirin-N facilitates PEGylation and potently inhibits HIV-1 by targeting the glycan ligand. Chen J; Huang D; Chen W; Guo C; Wei B; Wu C; Peng Z; Fan J; Hou Z; Fang Y; Wang Y; Kitazato K; Yu G; Zou C; Qian C; Xiong S PLoS One; 2014; 9(1):e86455. PubMed ID: 24475123 [TBL] [Abstract][Full Text] [Related]
57. Inhibition of human immunodeficiency virus type 1 activity in vitro by a new self-stabilized oligonucleotide with guanosine-thymidine quadruplex motifs. Suzuki J; Miyano-Kurosaki N; Kuwasaki T; Takeuchi H; Kawai G; Takaku H J Virol; 2002 Mar; 76(6):3015-22. PubMed ID: 11861867 [TBL] [Abstract][Full Text] [Related]
58. Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation. Kanamoto T; Kashiwada Y; Kanbara K; Gotoh K; Yoshimori M; Goto T; Sano K; Nakashima H Antimicrob Agents Chemother; 2001 Apr; 45(4):1225-30. PubMed ID: 11257038 [TBL] [Abstract][Full Text] [Related]
59. Glycyrrhizin as a promoter of the late signal transduction for interleukin-2 production by splenic lymphocytes. Zhang YH; Isobe K; Nagase F; Lwin T; Kato M; Hamaguchi M; Yokochi T; Nakashima I Immunology; 1993 Aug; 79(4):528-34. PubMed ID: 8406577 [TBL] [Abstract][Full Text] [Related]
60. Characterization of human T-cell lines harboring defective human immunodeficiency virus type 1. Hamamoto Y; Takamatsu K; Kobayashi S; Yamaguchi K; Yamamoto N; Kobayashi N Virus Genes; 1989 Nov; 3(2):141-52. PubMed ID: 2559541 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]